Fundamental and Frontier Research of Immune Responses to Influenza Vaccines in Human Aging: from Cross-sectional and Longitudinal Studies to Clinical Trials and the Geroscience Perspective

Overview

Journal Immun Ageing

Publisher Biomed Central

Specialty Geriatrics

Date 2023 Nov 29

PMID 38031077

Authors

Sean X Leng

Albert C Shaw

Affiliations

Soon will be listed here.

Citing Articles

Evaluating Nanoparticulate Vaccine Formulations for Effective Antigen Presentation and T-Cell Proliferation Using an In Vitro Overlay Assay.

Pasupuleti D, Bagwe P, Ferguson A, Uddin M, DSouza M, Zughaier S Vaccines (Basel). 2024; 12(9).

PMID: 39340079 PMC: 11435973. DOI: 10.3390/vaccines12091049.

References

Li X, Leng S . Influenza immunization among Chinese seniors: Urgent calling for improving vaccination coverage, education, and research. Aging Med (Milton). 2020; 3(1):12-15. PMC: 7099750. DOI: 10.1002/agm2.12103. View

Shapiro J, Seddu K, Park H, Lee J, Creisher P, Yin A . The intersection of biological sex and gender in adverse events following seasonal influenza vaccination in older adults. Immun Ageing. 2023; 20(1):43. PMC: 10463383. DOI: 10.1186/s12979-023-00367-3. View

Wunderlich B, Laskow T, Li H, Zhang L, Abrams E, Tian J . Interseason waning of vaccine-induced hemagglutination inhibition antibody titers and contributing factors to pre-existing humoral immunity against influenza in community-dwelling older adults 75 years and older. Immun Ageing. 2023; 20(1):38. PMC: 10388475. DOI: 10.1186/s12979-023-00362-8. View

Shapiro J, Li H, Morgan R, Chen Y, Kuo H, Ning X . Sex-specific effects of aging on humoral immune responses to repeated influenza vaccination in older adults. NPJ Vaccines. 2021; 6(1):147. PMC: 8660902. DOI: 10.1038/s41541-021-00412-6. View

Xiao T, Wei M, Guo X, Zhang Y, Wang Z, Xia X . Immunogenicity and safety of quadrivalent influenza vaccine among young and older adults in Tianjin, China: implication of immunosenescence as a risk factor. Immun Ageing. 2023; 20(1):37. PMC: 10373264. DOI: 10.1186/s12979-023-00364-6. View

Schmader K, Liu C, Flannery B, Rountree W, Auerbach H, Barnett E . Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial. Immun Ageing. 2023; 20(1):30. PMC: 10314373. DOI: 10.1186/s12979-023-00355-7. View

Liu Y, Zhang H, Yuan G, Yao M, Li B, Chen J . The impact of circadian rhythms on the immune response to influenza vaccination in middle-aged and older adults (IMPROVE): a randomised controlled trial. Immun Ageing. 2022; 19(1):46. PMC: 9574181. DOI: 10.1186/s12979-022-00304-w. View

Martin D, Cadar A, Panier H, Torrance B, Kuchel G, Bartley J . The effect of metformin on influenza vaccine responses in nondiabetic older adults: a pilot trial. Immun Ageing. 2023; 20(1):18. PMC: 10152024. DOI: 10.1186/s12979-023-00343-x. View

Cadar A, Martin D, Bartley J . Targeting the hallmarks of aging to improve influenza vaccine responses in older adults. Immun Ageing. 2023; 20(1):23. PMC: 10189223. DOI: 10.1186/s12979-023-00348-6. View

10.

Frasca D, Romero M, Diaz A, Blomberg B . Obesity accelerates age defects in B cells, and weight loss improves B cell function. Immun Ageing. 2023; 20(1):35. PMC: 10351107. DOI: 10.1186/s12979-023-00361-9. View